Clinical trial
Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients…
NCT00187486 · University of California, San Francisco, Other · Completed
Key facts
| NCT number | NCT00187486 |
|---|---|
| Title | Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors |
| Official title | Phase II Study of Tarceva Plus Temodar During and Following Radiation Therapy in Patients With Newly Diagnosed Glioblastoma Multiforme and Gliosarcoma |
| Lead sponsor | University of California, San Francisco, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Glioblastoma Multiforme, Gliosarcoma |
| Intervention type | Drug, Procedure |
| Interventions | Tarceva, Temodar, Radiation Therapy |
| Enrollment | 66 |
| Start date | Aug 1, 2004 |
| Primary completion | Mar 1, 2011 |
| Completion | Mar 1, 2011 |
| First posted | Sep 16, 2005 |
| Last update posted | Sep 5, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: